Article
Circulating tumour DNA in localised urological cancers
2017-01-01
Abstract excerpt
There is a need for informative biomarkers in localised urological cancers. At present, no method can accurately distinguish between indolent and aggressive prostate cancers, and men often require repeated biopsies. Patients with muscle invasive bladder cancer undergo neo-adjuvant chemotherapy (NAC) to improve survival. However many do not respond to NAC, delaying definitive treatment. Cell-free mutant DNA (mutDNA...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a0752ea1-0cc9-5922-b8ea-4a33cafa2782
- DOI
- 10.17863/cam.14290
